期刊文献+

组织工程血管补片动物模型的建立及围术期处理

Model Establishment of Tissue Engineering Extracardiac Conduit and Its Perioperational Management
下载PDF
导出
摘要 目的评估组织工程血管补片动物模型的可行性并总结模型建立的围手术期处理。方法10只成年杂种犬,用自身的骨髓细胞和高分子可降解材料构建的组织工程血管补片扩大肺动脉流出道。结果实验中有1例在术中出现心动过缓,暂停手术操作后,其余手术均逐渐恢复,未造成不良后果。术后实验动物均存活。术后5~10min撤离呼吸机,拔除胸引管。术后两周肺动脉造影示左肺动脉通畅,未见动脉瘤形成,移植物处稍狭窄;取出移植物观察,血管管腔通畅,腔面光滑,无血栓,无感染。结论通过自身的骨髓细胞和高分子可降解材料构建的组织工程血管补片扩大犬肺动脉流出道成功建立了组织工程血管补片动物模型。为了保证模型的成功建立,应使用右侧卧位、尽早进行心电监护、及时处理心律紊乱和尽早撤离呼吸机等围术期护理要点。 Objective To estimate the availability of tissue engineering extracardiac conduit animal model and sum up its perioperational management. Method The canine mesenchymal stem cells (BMCs) seeded biodegradable scaffold were implanted into the pulmonary artery of the ten dogs from which the BMCs were originally obtained. Results All animals survived the operative procedure, no bleeding occurred from the suture line. There was no stenosis or obstruction caused by the tissue-engineered autografts implanted into the dogs. Conclusions It is feasibile to establish extracardiac conduits animal model based on the use of the autologous BMCs and three-dimensional, biodegradable scaffold by tissue engineering technique. It is noted that right arm recumbent, early, timely prevention of cardiac dysrhythmia, early use of electrocardio-monitor and evacuation of breathing machine are essential for succeed in establishing this animal model.
出处 《中国比较医学杂志》 CAS 2008年第1期9-11,I0002,共4页 Chinese Journal of Comparative Medicine
关键词 组织工程血管补片 模型 动物 围手术期处理 Tissue engineering extracardiac conduit Model, animal Perioperational management
  • 相关文献

参考文献3

二级参考文献11

  • 1Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vitro. Science, 1999,284:489-493.
  • 2Matsumura G, Miyagawa-Tomita S, Shin'oka T,et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation, 2003,108:1729-1734.
  • 3Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood,1998,92:362-367.
  • 4Simper D, Stalboerger PG, Panetta CJ, et al. Smooth muscle progenitor cells in human blood. Circulation, 2002,106:1199-1204.
  • 5Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997,275:964-967.
  • 6Kang SS, Gosselin C, Ren D, et al. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions. Surgery,1995,118:280-286.
  • 7Greisler HP, Gosselin C, Ren D, et al. Biointeractive polymers and tissue engineered blood vessels. Biomaterials, 1996,17:329-336.
  • 8Fujita Y, Wu MH-D, Ishida A, et al. Accelerated healing of Dacron grafts seeded by preclotting with autologous bone marrow blood. Ann Vasc Surg,1999,13:402-412.
  • 9Bhattacharya V, McSweeney PA, Shi Q, et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood,2000,95:581-585.
  • 10刘锦纷,心肺血管病杂志,1994年,13卷,12页

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部